For 2025, West Pharmaceutical guided for sales between $2.88 billion and $2.91 billion as well as adjusted earnings per-share in the range of $6 and $6.20. Analysts polled by FactSet expected $3.04 ...

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q4 CY2024 results , with sales up 2.3% year on year to $748.8 million. On the other hand, the company’s full-year revenue ...

Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting earnings tomorrow morning. Here’s what ...

Vietnam’s amended Law on Pharmacy, set to take effect on July 1, 2025, introduces key reforms to modernize the pharmaceutical ...

Bain Capital has agreed to acquire Mitsubishi Chemical Group's pharmaceutical business for more than $3 billion, a deal that would allow the Japanese company to focus on its key chemical businesses.

Adragos Pharma, a global pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Munich, ...

Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO) and bioanalytical Contract ...

Ardena's drug product manufacturing facility in Somerset Advanced drug product manufacturing facility acquired by Ardena in ...

The highly anticipated 3rd edition of Pharma Live Expo & Summit 2025, a premier event for the global pharmaceutical, ...

Syngene is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical ...

• Based on services, the consulting segment dominated the market in 2025. The high segment growth is driven by increasing changes in regulations by several regulatory authorities such as U.S. FDA and ...